Riversedge Advisors’s Elevance Health ELV Stock Holding History

Riversedge Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$438K	Buy	+1,125	New	+$449K	0.05%	169

Other funds holding ELV

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Riversedge Advisors's ELV Position: Q3 2026 in Review

Riversedge Advisors opened a new position in Elevance Health (ELV) in Q3 2026: 1,125 shares worth $438K. The stake represents 0.05% of the portfolio and ranks #169 among its holdings.

1,031 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

Riversedge Advisors held 1,125 shares of Elevance Health worth $438K as of Q3 2026.
Elevance Health was a new Riversedge Advisors position in Q3 2026.
Elevance Health made up 0.05% of Riversedge Advisors's portfolio in Q3 2026, its #169 holding.
1,031 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Riversedge Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.